Janus Henderson Group PLC decreased its stake in Varian Medical Systems, Inc. (NYSE:VAR) by 8.1% in the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 2,173,877 shares of the medical equipment provider’s stock after selling 192,676 shares during the quarter. Janus Henderson Group PLC owned about 2.39% of Varian Medical Systems worth $295,929,000 at the end of the most recent reporting period.
Several other institutional investors also recently made changes to their positions in VAR. Arrow Financial Corp acquired a new position in shares of Varian Medical Systems in the 2nd quarter valued at about $27,000. Permanens Capital L.P. acquired a new position in shares of Varian Medical Systems in the 1st quarter valued at about $28,000. Financial Gravity Wealth Inc. lifted its holdings in shares of Varian Medical Systems by 1,646.2% in the 2nd quarter. Financial Gravity Wealth Inc. now owns 227 shares of the medical equipment provider’s stock valued at $31,000 after buying an additional 214 shares during the period. Flagship Harbor Advisors LLC acquired a new position in shares of Varian Medical Systems in the 2nd quarter valued at about $32,000. Finally, Global Retirement Partners LLC lifted its holdings in shares of Varian Medical Systems by 30.1% in the 1st quarter. Global Retirement Partners LLC now owns 462 shares of the medical equipment provider’s stock valued at $65,000 after buying an additional 107 shares during the period. Hedge funds and other institutional investors own 91.15% of the company’s stock.
In other Varian Medical Systems news, Director Timothy E. Guertin sold 12,651 shares of the stock in a transaction that occurred on Monday, July 15th. The stock was sold at an average price of $135.21, for a total transaction of $1,710,541.71. Following the completion of the transaction, the director now owns 13,589 shares of the company’s stock, valued at $1,837,368.69. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP John W. Kuo sold 465 shares of the stock in a transaction that occurred on Wednesday, May 15th. The shares were sold at an average price of $130.11, for a total value of $60,501.15. Following the transaction, the senior vice president now directly owns 35,566 shares of the company’s stock, valued at approximately $4,627,492.26. The disclosure for this sale can be found here. Insiders sold a total of 74,150 shares of company stock valued at $9,866,686 in the last ninety days. 0.74% of the stock is currently owned by insiders.
NYSE VAR traded up $1.60 during trading hours on Tuesday, reaching $111.15. The company’s stock had a trading volume of 6,105 shares, compared to its average volume of 720,584. The stock has a market capitalization of $10.14 billion, a price-to-earnings ratio of 24.79, a price-to-earnings-growth ratio of 3.01 and a beta of 0.84. Varian Medical Systems, Inc. has a 1-year low of $101.42 and a 1-year high of $142.50. The firm has a 50-day moving average price of $128.24.
Varian Medical Systems (NYSE:VAR) last released its quarterly earnings results on Wednesday, July 24th. The medical equipment provider reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.14 by $0.18. The company had revenue of $825.80 million during the quarter, compared to analysts’ expectations of $762.29 million. Varian Medical Systems had a return on equity of 24.91% and a net margin of 10.75%. Varian Medical Systems’s quarterly revenue was up 16.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.04 EPS. As a group, analysts anticipate that Varian Medical Systems, Inc. will post 4.62 earnings per share for the current year.
Varian Medical Systems Company Profile
Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment.
Featured Article: What does cost of debt say about a company’s financial health?
Want to see what other hedge funds are holding VAR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varian Medical Systems, Inc. (NYSE:VAR).
Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.